1. Home
  2. TEX vs PCVX Comparison

TEX vs PCVX Comparison

Compare TEX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terex Corporation

TEX

Terex Corporation

HOLD

Current Price

$59.71

Market Cap

7.6B

Sector

Industrials

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$55.25

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEX
PCVX
Founded
1933
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TEX
PCVX
Price
$59.71
$55.25
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$71.00
$98.33
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
05-12-2026
05-27-2026
Dividend Yield
1.14%
N/A
EPS Growth
N/A
N/A
EPS
3.33
N/A
Revenue
$5,421,000,000.00
N/A
Revenue This Year
$47.78
N/A
Revenue Next Year
$7.13
N/A
P/E Ratio
$17.88
N/A
Revenue Growth
5.73
N/A
52 Week Low
$31.53
$28.09
52 Week High
$71.50
$76.61

Technical Indicators

Market Signals
Indicator
TEX
PCVX
Relative Strength Index (RSI) 39.30 45.44
Support Level $58.60 $42.30
Resistance Level $62.37 $56.04
Average True Range (ATR) 2.47 2.72
MACD -1.13 -0.86
Stochastic Oscillator 9.73 23.13

Price Performance

Historical Comparison
TEX
PCVX

About TEX Terex Corporation

Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: